Impacto de la cirugía bariátrica en la incidencia de diferentes cánceres. Revisión narrativa

Autores/as

DOI:

https://doi.org/10.22516/25007440.951

Palabras clave:

Obesidad, Cáncer, Cirugía bariátrica, Cirugía metabólica

Resumen

La obesidad es una epidemia global, según la Organización Mundial de la Salud (OMS) se define como una acumulación anormal o excesiva de grasa que puede ser perjudicial para la salud, su incidencia está aumentando de forma alarmante en los países en desarrollo. Asimismo, es un factor de riesgo importante para el desarrollo de enfermedades crónicas como la diabetes mellitus tipo 2, hipertensión arterial, enfermedad coronaria, enfermedad del hígado graso no alcohólico y trastornos musculoesqueléticos como la osteoartritis; además, se han encontrado asociaciones entre la obesidad y el desarrollo del cáncer de próstata, hígado, vesícula biliar, riñón, colon, endometrio, mama y ovarios. La cirugía bariátrica y metabólica es el tratamiento más eficaz para la obesidad mórbida y sus comorbilidades, esta cirugía puede reducir la mortalidad general en un 40% a los diez años por desenlaces cardiovasculares, diabetes o cáncer, como también mejorar enfermedades metabólicas como la diabetes tipo 2.

Descargas

Los datos de descargas todavía no están disponibles.

Biografía del autor/a

Santiago Otero-Parra, Pontificia Universidad Javeriana

Estudiante de medicina, Pontificia universidad Javeriana. Bogotá, Colombia.

Juliana Pineda-Ortega, Pontificia Universidad Javeriana

Estudiante de medicina, Pontificia universidad Javeriana. Bogotá, Colombia.

Jorge Sebastián Ramírez-Valbuena, Pontificia Universidad Javeriana

Estudiante de medicina, Pontificia universidad Javeriana. Bogotá, Colombia.

William Otero Regino MD., Universidad Nacional de Colombia

Médico cirujano, Especialista en medicina interna, gastroenterología y epidemiología. Coordinador de gastroenterología en Hospital Universitario Nacional de Colombia. Profesor de gastroenterología. Bogotá, Colombia.

Referencias bibliográficas

Siegel RL, Miller KD, Jemal A. Cancer statistics. CA Cancer J Clin. 2020;70(1):7-30. https://doi.org/10.3322/caac.21590

Haslam DW, James WP. Obesity. Lancet. 2005;366(9492):1197-209. https://doi.org/10.1016/S0140-6736(05)67483-1

Salaün H, Thariat J, Vignot M, Merrouche Y, Vignot S. Obésité et cáncer [Obesity and cancer]. Bull cancer. 2017;104(1):30-41. https://doi.org/10.1016/j.bulcan.2016.11.012Get

Lauby-Secretan B, Dossus L, Marant-Micallef C, His M. Obesity and cancer. Bull Cancer. 2019;106(7-8):635-646. https://doi.org/10.1016/j.bulcan.2019.04.008

Annett S, Moore G, Robson T. Obesity and cancer metastasis: Molecular and translational perspectives. Cancers (Basel). 2020;12(12):3798. https://doi.org/10.3390/cancers12123798

Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003;348(17):1625-38. https://doi.org/10.1056/NEJMoa021423

Apovian M, Ard JD, Comuzzie AG, Donato KA, Hu FB, Hubbard VS, et al. 2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults: HHS Public Access Preamble and Transition to ACC/AHA Guidelines to Reduce Cardiovascular Risk. Circulation. 2014;129(25):10238. https://doi.org/10.1161/01.cir.0000437739.71477.ee

Busetto L, Dicker D, Azran C, Batterham RL, Farpour-Lambert N, Fried M, et al. Practical Recommendations of the Obesity Management Task Force of the European Association for the Study of Obesity for the Post-Bariatric Surgery Medical Management. Obesity Facts. 2018;10(6):597-632. https://doi.org/10.1159/000481825

Xu G, Song M. Recent advances in the mechanisms underlying the beneficial effects of bariatric and metabolic surgery. Surg Obes Relat Dis. 2021;17(1):231-8. https://doi.org/10.1016/j.soard.2020.08.028

Carlsson LM, Peltonen M, Ahlin S, Anveden Å, Bouchard C, Carlsson B, et al. Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects. N Engl J Med. 2012;367(8):695-704. https://doi.org/10.1056/NEJMoa1112082

Ozsoy Z, Demir E. Which Bariatric Procedure Is the Most Popular in the World? A Bibliometric Comparison. Obes Surg. 2018;28(8):2339-2352. https://doi.org/10.1007/s11695-018-3163-6

Arterburn D, Wellman R, Emiliano A, Smith SR, Odegaard AO, Murali S, Et al; PCORnet Bariatric Study Collaborative. Comparative Effectiveness and Safety of Bariatric Procedures for Weight Loss: A PCORnet Cohort Study. Ann Intern Med. 2018;169(11):741-50. https://doi.org/10.7326/M17-2786

Smith BR, Schauer P, Nguyen NT. Surgical approaches to the treatment of obesity: bariatric surgery. Endocrinol Metab Clin North Am. 2008;37(4):943-64. https://doi.org/10.1016/j.ecl.2008.08.001

Chevallier JM. De la chirurgie de l’obésité a la chirurgie a visée métabolique. Expérience de quinze ans dans un service hospitalier universitaire [From bariatric to metabolic surgery: 15 years experience in a French university hospital]. Bull Acad Natl Med. 2010;194(1):25-36. https://doi.org/10.1016/S0001-4079(19)32359-3

Buchwald H. The evolution of metabolic/bariatric surgery. Obes Surg. 2014;24(8):1126-35. https://doi.org/ 10.1007/s11695-014-1354-3

McDonald ME, Bender DP. Endometrial cancer. Obstet Gynecol Clin North Am. 2019;46(1):89-105. https://doi.org/10.1016/j.ogc.2018.09.006

Creasman WT, Odicino F, Maisonneuve P, Quinn MA, Beller U, Benedet JL, et al. Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet. 2006;95 Suppl 1:S105-43. https://doi.org/10.1016/S0020-7292(06)60031-3

Von Gruenigen VE, Gil KM, Frasure HE, Jenison EJ, Hopkins MP. The impact of obesity and age on quality of life in gynecologic surgery. Am J Obstet Gynecol. 2005;193(4):1369-7. https://doi.org/10.1016/j.ajog.2005.03.038

Shaw E, Farris M, McNeil J, Friedenreich C. Obesity and Endometrial Cancer. Recent Results Cancer Res. 2016;208:107-136. https://doi.org/10.1007/978-3-319-42542-9_7

Bravi F, Scotti L, Bosetti C, Zucchetto A, Talamini R, Montella M, et al. Food groups and endometrial cancer risk: a case–control study from Italy. Am J Obstet Gynecol. 2009;200(3):293.e1-7. https://doi.org/10.1016/j.ajog.2008.09.015

Fader AN, Arriba LN, Frasure HE, von Gruenigen VE. Endometrial cancer and obesity: Epidemiology, biomarkers, prevention and survivorship. Gynecologic Oncology. 2009;114(1):121-7. https://doi.org/10.1016/j.ygyno.2009.03.039

Luo J, Beresford S, Chen C, Chlebowski R, Garcia L, Kuller L, et al. Association between diabetes, diabetes treatment and risk of developing endometrial cancer. Br J Cancer. 2014;111(7):1432-9. https://doi.org/10.1038/bjc.2014.407

Friberg E, Orsini N, Mantzoros CS, Wolk A. Diabetes mellitus and risk of endometrial cancer: a meta-analysis. Diabetologia. 2007;50(7):1365-74. https://doi.org/10.1007/s00125-007-0681-5

Anderson KE, Anderson E, Mink PJ, Ching Ping H, Kushi LH, Sellers TA, et al. Diabetes and endometrial cancer in the Iowa Women’s Health Study. Cancer Epidemiol Biomark Prev. 2001;10(6):611-6.

Mu N, Zhu Y, Wang Y, Zhang H, Xue F. Insulin resistance: a significant risk factor of endometrial cancer. Gynecol Oncol. 2012;125(3):751-7. https://doi.org/10.1016/j.ygyno.2012.03.032

Tao W, Santoni G, von Euler-Chelpin M, Ljung R, Lynge E, Pukkala E, et al. Cancer Risk After Bariatric Surgery in a Cohort Study from the Five Nordic Countries. Obes Surg. 2020;30(10):3761-3767. https://doi.org/10.1007/s11695-020-04751-6

Zhang K, Luo Y, Dai H, Deng Z. Effects of Bariatric Surgery on Cancer Risk: Evidence from Meta-analysis. Obes Surg. 2020;30(4):1265-1272. https://doi.org/10.1007/s11695-019-04368-4

Upala S, Sanguankeo A. Bariatric surgery and risk of postoperative endometrial cancer: a systematic review and meta-analysis. Surg Obes Relat Dis. 2015;11(4):949-55. https://doi.org/10.1016/j.soard.2014.09.024

Barzaman K, Karami J, Zarei Z, Hosseinzadeh A, Kazemi MH, Moradi-Kalbolandi S, et al. Breast cancer: Biology, biomarkers, and treatments. Int Immunopharmacol. 2020;84:106535. https://doi.org/10.1016/j.intimp.2020.106535

Loibl S, Poortmans P, Morrow M, Denkert C, Curigliano G. Breast cancer. Lancet. 2021;397(10286):1750-1769. https://doi.org/10.1016/S0140-6736(20)32381-3

Waks AG, Winer EP. Breast cancer treatment. JAMA. 2019;321(3):288-300. https://doi.org/10.1001/jama.2018.19323

Sun YS, Zhao Z, Yang ZN, Xu F, Lu HJ, Zhu ZY, et al. Risk Factors and Preventions of Breast Cancer. Int J Biol Sci. 2017;13(11):1387-97. https://doi.org/10.7150/ijbs.21635

Suzuki R, Orsini N, Saji S, Key TJ, Wolk A. Body weight and incidence of breast cancer defined by estrogen and progesterone receptor status-A meta-analysis. Int J Cancer. 2009;124(3):698-712. https://doi.org/10.1002/ijc.23943

Neuhouser ML, Aragaki AK, Prentice RL, Manson JE, Chlebowski R, Carty CL, et al. Overweight, Obesity, and Postmenopausal Invasive Breast Cancer Risk. JAMA Oncol. 2015;1(5):611-21. https://doi.org/10.1001/jamaoncol.2015.1546

Wiggins T, Antonowicz SS, Markar SR. Cancer Risk Following Bariatric Surgery-Systematic Review and Meta-analysis of National Population-Based Cohort Studies. Obesity Surgery. 2019;29(3):1031-1039. https://doi.org/10.1007/s11695-018-3501-8

Pernar CH, Ebot EM, Wilson KM, Mucci LA. The Epidemiology of Prostate Cancer. Cold Spring Harb Perspect Med. 2018;8(12):a030361. https://doi.org/10.1101/cshperspect.a030361

Masuda H, Kagawa M, Kawakami S, Numao N, Matsuoka Y, Yokoyama M, et al. Body mass index influences prostate cancer risk at biopsy in Japanese men. Int J Urol. 2012;20(7):701-7. https://doi.org/10.1111/iju.12023

Ostlund MP, Lu Y, Lagergren J. Risk of obesity-related cancer after obesity surgery in a population-based cohort study. Ann Surg. 2010;252(6):972-6. https://doi.org/10.1097/SLA.0b013e3181e33778

Liao LM, Hofmann JN, Cho E, Pollak MN, Chow W-H, Purdue MP. Circulating levels of obesity-related markers and risk of renal cell carcinoma in the PCO cancer screening trial. Cancer. Causes Control. 2017;28(7):801-7. https://doi.org/10.1007/s10552-017-0901-3

Klinghoffer Z, Yang B, Kapoor A, Pinthus JH. Obesity and renal cell carcinoma: epidemiology, underlying mechanisms and management considerations. Expert Rev Anticancer Ther. 2009;9(7):975-87. https://doi.org/10.1586/era.09.51

Capitanio U, Bensalah K, Bex A, Boorjian SA, Bray F, Coleman J, et al. Epidemiology of Renal Cell Carcinoma. Eur Urol. 2019;75(1):74-84. https://doi.org/10.1016/j.eururo.2018.08.036

Bergström A, Hsieh CC, Lindblad P, Lu CM, Cook NR, Wolk A. Obesity and renal cell cancer—a quantitative review. Br J Cancer. 2001;85(7):984-90. https://doi.org/10.1054/bjoc.2001.2040

Marrero JA, Fontana RJ, Su GL, Conjeevaram HS, Emick DM, Lok AS. NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States. Hepatology. 2002;36(6):1349-54. https://doi.org/10.1053/jhep.2002.36939

Botero-Fonnegra C, Funes DR, Valera RJ, Gómez CO, Lo Menzo E, Szomstein S, et al. Potential beneficial effects of bariatric surgery on the prevalence of kidney cancer: a national database study. Surg Obes Relat Dis. 2022;18(1):102-106. https://doi.org/10.1016/j.soard.2021.08.012

Webb PM, Jordan SJ. Epidemiology of epithelial ovarian cancer. Best Pract Res Clin Obstet Gynaecol. 2017;41:3-14. https://doi.org/10.1016/j.bpobgyn.2016.08.006

Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359-86. https://doi.org/10.1002/ijc.29210

Duggan MA, Anderson WF, Altekruse S, Penberthy L, Sherman ME. The Surveillance, Epidemiology, and End Results (SEER) Program and Pathology: Toward Strengthening the Critical Relationship. Am J Surg Pathol. 2016;40(12):e94-e102. https://doi.org/10.1097/PAS.0000000000000749

Renehan AG, Zwahlen M, Egger M. Adiposity and cancer risk: new mechanistic insights from epidemiology. Nat Rev Cancer. 2015;15(8):484-98. https://doi.org/10.1038/nrc3967

Au-Yeung G, Webb PM, DeFazio A, Fereday S, Bressel M, Mileshkin L. Impact of obesity on chemotherapy dosing for women with advanced stage serous ovarian cancer in the Australian Ovarian Cancer Study (AOCS). Gynecol Oncol. 2014;133(1):16-22. https://doi.org/10.1016/j.ygyno.2014.01.030

Bhaskaran K, Douglas I, Forbes H, dos-Santos-Silva I, Leon DA, Smeeth L. Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5·24 million UK adults. Lancet. 2014;384(9945):755-65. https://doi.org/10.1016/S0140-6736(14)60892-8

Ishihara BP, Farah D, Fonseca MCM, Nazario A. The risk of developing breast, ovarian, and endometrial cancer in obese women submitted to bariatric surgery: a meta-analysis. Surg Obes Relat Dis. 2020;16(10):1596-1602. https://doi.org/10.1016/j.soard.2020.06.008

Guggenheim DE, Shah MA. Gastric cancer epidemiology and risk factors. J Surg Oncol. 2013;107(3):230-6. https://doi.org/10.1002/jso.23262

Crew KD, Neugut AI. Epidemiology of gastric cancer. World J Gastroenterol. 2006;12(3):354-62. https://doi.org/10.3748/wjg.v12.i3.354

Thrift AP, El-Serag HB. Burden of Gastric Cancer. Clin Gastroenterol Hepatol. 2020;18(3):534-542. https://doi.org/10.1016/j.cgh.2019.07.045

Orlando G, Pilone V, Vitiello A, Gervasi R, Lerose MA, Silecchia G, et al. Gastric cancer following bariatric surgery: a review. Surg Laparosc Endosc Percutan Tech. 2014;24(5):400-5. https://doi.org/10.1097/SLE.0000000000000050

Otero W, Otero L, Trespalacios AA. Prevalencia de Helicobacter pylori y alteraciones endoscópicas en pacientes con obesidad severa sin síntomas gastrointestinales programados para cirugía bariátrica. Rev Col Gastroenterol. 2015;30(2):165-70. https://doi.org/10.22516/25007440.36

Altekruse SF, McGlynn KA, Reichman ME. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol. 2009;27(9):1485-91. https://doi.org/10.1200/JCO.2008.20.7753

Singal AG, El-Serag HB. Hepatocellular Carcinoma From Epidemiology to Prevention: Translating Knowledge into Practice. Clin Gastroenterol Hepatol. 2015;13(12):2140-51. https://doi.org/10.1016/j.cgh.2015.08.014

Lau LHS, Wong SH. Microbiota, Obesity and NAFLD. Adv Exp Med Biol. 2018;1061:111-125. https://doi.org/10.1007/978-981-10-8684-7_9

Orci LA, Sanduzzi-Zamparelli M, Caballol B, Sapena V, Colucci N, Torres F, et al. Incidence of Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review, Meta-analysis, and Meta-regression. Clin Gastroenterol Hepatol. 2022;20(2):283-292.e10. https://doi.org/10.1016/j.cgh.2021.05.002

Milić S, Lulić D, Štimac D. Non-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations. World J Gastroenterol. 2014;20(28):9330-7. https://doi.org/10.3748/wjg.v20.i28.9330

Dixon JB, Bhathal PS, O’Brien PE. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology. 2001;121(1):91-100. https://doi.org/10.1053/gast.2001.25540

Sepulveda-Villegas M, Roman S, Rivera-Iñiguez I, Ojeda-Granados C, Gonzalez-Aldaco K, Torres-Reyes LA, et al. High prevalence of nonalcoholic steatohepatitis and abnormal liver stiffness in a young and obese Mexican population. PLoS One. 2019;14(1):e0208926. https://doi.org/10.1371/journal.pone.0208926

Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003;348(17):1625-38. https://doi.org/10.1056/NEJMoa021423

Wolk A, Gridley G, Svensson M, Nyrén O, McLaughlin JK, Fraumeni JF, et al. A prospective study of obesity and cancer risk (Sweden). Cancer Causes Control. 2001;12(1):13-21. https://doi.org/10.1023/a:1008995217664

Nair S, Mason A, Eason J, Loss G, Perrillo RP. Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis? Hepatology. 2002;36(1):150-5. https://doi.org/10.1053/jhep.2002.33713

Larsson SC, Wolk A. Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies. Br J Cancer. 2007;97(7):1005-8. https://doi.org/10.1038/sj.bjc.6603932

Sohn W, Lee HW, Lee S, Lim JH, Lee MW, Park CH, et al. Obesity and the risk of primary liver cancer: A systematic review and meta-analysis. Clin Mol Hepatol. 2021;27(1):157-174. https://doi.org/10.3350/cmh.2020.0176

Ramai D, Facciorusso A. Liver Cancer Reduction After Bariatric Surgery: Time to Expand Its Indication? Gastroenterology. 2021;161(6):2063. https://doi.org/10.1053/j.gastro.2021.03.053

Rustgi VK, Li Y, Gupta K, Minacapelli CD, Bhurwal A, Catalano C, et al. Bariatric Surgery Reduces Cancer Risk in Adults With Nonalcoholic Fatty Liver Disease and Severe Obesity. Gastroenterology. 2021;161(1):171-184.e10. https://doi.org/10.1053/j.gastro.2021.03.021

Michaud DS. Obesity and Pancreatic cancer. Recent Results Cancer Res. 2016;208:95-105. https://doi.org/10.1007/978-3-319-42542-9_6

Rawla P, Thandra KC, Sunkara T. Pancreatic cancer and obesity: epidemiology, mechanism, and preventive strategies. Clin J Gastroenterol. 2019;12(4):285-291. https://doi.org/10.1007/s12328-019-00953-3

Parkin DM, Boyd L, Walker LC. 16. The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010. Br J Cancer. 2011;105(2):77-81. https://doi.org/10.1038/bjc.2011.489

Li D, Morris JS, Liu J, Hassan MM, Day RS, Bondy ML, Abbruzzese JL. Body mass index and risk, age of onset, and survival in patients with pancreatic cancer. JAMA. 2009;301(24):2553-62. https://doi.org/10.1001/jama.2009.886

Brenner H, Kloor M, Pox CP. Colorectal cancer. Lancet. 2014;383(9927):1490-1502. https://doi.org/10.1016/S0140-6736(13)61649-9

Robsahm TE, Aagnes B, Hjartaker A, Langseth H, Bray FI, Larsen IK. Body mass index, physical activity, and colorectal cancer by anatomical subsites: a systematic review and meta-analysis of cohort studies. Eur J Cancer Prev. 2013;22(6):492-505. https://doi.org/10.1097/CEJ.0b013e328360f434

Aran V, Victorino AP, Thuler LC, Ferreira CG. Colorectal Cancer: Epidemiology, Disease Mechanisms and Interventions to Reduce Onset and Mortality. Clin Colorectal Cancer. 2016;15(3):195-203. https://doi.org/10.1016/j.clcc.2016.02.008

Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al: Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359-386. https://doi.org/10.1002/ijc.29210

Freedman AN, Slattery ML, Ballard-Barbash R, Willis G, Cann BJ, Pee D, et al. Colorectal cancer risk prediction tool for white men and women without known susceptibility. J Clin Oncol. 2009;27(5):686-693. https://doi.org/10.1200/JCO.2008.17.4797

Harriss DJ, Atkinson G, George K, Cable NT, Reilly T, Haboubi N, et al. C-CLEAR group. Lifestyle factors and colorectal cancer risk (1): systematic review and meta-analysis of associations with body mass index. Colorectal Dis. 2009;11(6):547-63. https://doi.org/10.1111/j.1463-1318.2009.01766.x

Matsuo K, Mizoue T, Tanaka K, Tsuji I, Sugawara Y, Sasazuki S, et al. Development and Evaluation of Cancer Prevention Strategies in Japan. Association between body mass index and the colorectal cancer risk in Japan: pooled analysis of population-based cohort studies in Japan. Ann Oncol. 2012;23(2):479-90. https://doi.org/10.1093/annonc/mdr143

Afshar S, Kelly SB, Seymour K, Lara J, Woodcock S, Mathers JC. The effects of bariatric surgery on colorectal cancer risk: systematic review and meta-analysis. Obes Surg. 2014;24(10):1793-9. https://doi.org/10.1007/s11695-014-1359-y

Tabla 1. Asociaciones entre obesidad y cáncer

Publicado

2023-09-27

Cómo citar

Otero Parra, S., Pineda Ortega, J., Ramírez Valbuena, J. S., & Otero Regino, W. A. (2023). Impacto de la cirugía bariátrica en la incidencia de diferentes cánceres. Revisión narrativa. Revista Colombiana De Gastroenterología, 38(3), 321–331. https://doi.org/10.22516/25007440.951

Número

Sección

Revisión de tema

Métricas

Crossref Cited-by logo
Estadísticas de artículo
Vistas de resúmenes
Vistas de PDF
Descargas de PDF
Vistas de HTML
Otras vistas
QR Code

Algunos artículos similares: